Literature DB >> 1760538

Regulation of taurine transporter activity in LLC-PK1 cells: role of protein synthesis and protein kinase C activation.

D P Jones1, L A Miller, C Dowling, R W Chesney.   

Abstract

Taurine transporter activity increases after exposure of cultured renal epithelial cells to taurine-free medium for 24 h and decreases after incubation in high (500 microM) taurine. This adaptive response mimics that observed in rat kidney after manipulation of dietary taurine. In order to elucidate potential mechanisms involved in the regulation of beta-amino acid transporter activity, the role of RNA transcription, protein synthesis, and protein import (trafficking), as well as protein kinase C activation, on the control of taurine transport was examined in the continuous proximally derived LLC-PK1 renal cell line. Inhibition of RNA transcription with actinomycin D did not alter the up-regulatory and down-regulatory adaptive responses. Inhibition of protein synthesis with cycloheximide prevented the increased taurine transport in response to taurine-free medium as well as the decrease in taurine transport after exposure to high taurine. Colchicine prevented the response to taurine-free medium but had no effect on the response to high-taurine medium. Exposure of confluent cell monolayers to the active phorbol esters, phorbol 12-myristate 13-acetate and phorbol 12,13 dibutyrate, resulted in a reduction in taurine uptake. The effect was seen within minutes of exposure but was not observed in the presence of the inactive phorbol 4-alpha. This inhibitory action was blocked by staurosporin, an inhibitor of protein kinase C (PKC). Treatment of cells with the diacylglycerol kinase inhibitor R59022, which results in increased intracellular diacylglycerol, a natural stimulant of PKC, also inhibited taurine uptake, providing further evidence for a specific effect of PKC activation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760538     DOI: 10.1681/ASN.V251021

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Taurine transport in cultured choroid plexus.

Authors:  V K Ramanathan; S J Chung; K M Giacomini; C M Brett
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

2.  Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells.

Authors:  C C Bridges; M S Ola; P D Prasad; A El-Sherbeny; V Ganapathy; S B Smith
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

3.  Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells.

Authors:  Hideo Satsu; Eriko Terasawa; Yu Hosokawa; Makoto Shimizu
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 4.  The role of protein phosphorylation in renal amino acid transport.

Authors:  I Zelikovic; J Przekwas
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 5.  Renal amino acid transport: cellular and molecular events from clearance studies to frog eggs.

Authors:  R W Chesney; D Jones; I Zelikovic
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 6.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

7.  Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl(-)-dependent taurine transporter that is regulated by hypertonicity.

Authors:  S Uchida; H M Kwon; A Yamauchi; A S Preston; F Marumo; J S Handler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 8.  Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Maria Goulielmaki; Michalis I Panayiotidis; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.